A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children-Reference-Cited by-同舟云学术

A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children

Published:2016-01-30 Issue:4 Volume:81 Page:679-687
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Schipani Alessandro¹,Pertinez Henry¹,Mlota Rachel²,Molyneux Elizabeth²,Lopez Nuria²,Dzinjalamala Fraction K.²,van Oosterhout Joep J.²³,Ward Steve A.⁴,Khoo Saye¹,Davies Gerry¹

Affiliation:

1. Department of Pharmacology and Therapeutics; University of Liverpool; Liverpool UK

2. Department of Medicine; University of Malawi College of Medicine; Blantyre Malawi

3. Dignitas International; Zomba Malawi

4. Liverpool school of Tropical Medicine; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12848/fullpdf

Reference45 articles.

1. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project;Dye;JAMA,1999

2. Studies on the treatmentof tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications;Fox;Int J Tuberc Lung Dis,2001

3. Rifabutin for treating pulmonary tuberculosis;Davies;Cochrane Database Syst Rev,2007

4. Therapeutic drug monitoring in antituberculosis chemotherapy;Peloquin;Ther Drug Monit,1999

5. Pharmacokinetics of rifapentine in children;Blake;Pediatr Infect Dis J,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?;Pharmaceutics;2024-07-23

2. Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers;European Journal of Clinical Pharmacology;2024-05-09

3. The TuberXpert project protocol: Towards a Clinical Decision Support System for therapeutic anti-tuberculosis medical drugs monitoring in Tanzania;2023-12-24

4. Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii;International Journal of Antimicrobial Agents;2023-09

5. Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis;Tuberculosis;2023-03